CoChat
Sign Up
Cited by 194

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Amyloid-β causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons

Chiba, T, Yamada, M, Sasabe, J, Terashita, K, Shimoda, M, Matsuoka, M, Aiso, S·2009·Molecular Psychiatry
DOI 10.1038/mp.2008.105
Open this paper in CoChat — free account

Abstract

Elevation of intracranial soluble amyloid-beta (Abeta) levels has been implicated in the pathogenesis of Alzheimer's disease (AD). Intracellular events in neurons, which lead to memory loss in AD, however, remain elusive. Humanin (HN) is a short neuroprotective peptide abolishing Abeta neurotoxicity. Recently, we found that HN derivatives activate the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling axis. We here report that an HN derivative named colivelin completely restored cognitive function in an AD model (Tg2576) by activating the JAK2/STAT3 axis. In accordance, immunofluorescence staining using a specific antibody against phospho- (p-) STAT3 revealed that p-STAT3 levels in hippocampal neurons age-dependently decreased in both AD model mice and AD patients. Intracerebroventricular administration of Abeta1-42 downregulated p-STAT3 whereas passive immunization with anti-Abeta antibody conversely restored hippocampal p-STAT3 levels in Tg2576 mice, paralleling the decrease in the brain Abeta burden. Abeta1-42 consistently modulated p-STAT3 levels in primary neurons. Pharmacological inhibition of the JAK2/STAT3 axis not only induced significant loss of spatial working memory by downregulating an acetylcholine-producing enzyme choline acetyltransferase but also desensitized the M(1)-type muscarinic acetylcholine receptor. Thus, we propose a novel theory accounting for memory impairment related to AD: Abeta-dependent inactivation of th…

Overview

Integrity signals

Registry

Crossref · 10.1038/mp.2008.105

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Administration of Aβ has been shown to cause leptin resistance.

    “Administration of Aβ has been shown to cause leptin resistance (Figure 5).”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [122]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Mattson M . Pathways towards and away from Alzheimer's disease. Nature 2004; 430: 631–639. · DOI · Paper page
  2. Hashimoto Y, Niikura T, Tajima M, Yasukawa T, Sudo H, Ito Y et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proc Natl Acad Sci USA 2001; 98: 6336–6341. [erratum in Proc Natl Acad Sci USA 2001; 98: 12854]. · DOI
  3. Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait AC et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003; 423: 456–461. · DOI
  4. Chiba T, Nishimoto I, Aiso S, Matsuoka M . Neuroprotection against neurodegenerative diseases. Mol Neurobiol 2007; 35: 55–84. · DOI
  5. Hashimoto Y, Suzuki H, Aiso S, Niikura T, Nishimoto I, Matsuoka M . Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection. Life Sci 2005; 77: 3092–3104. · DOI
  6. Chiba T, Yamada M, Hashimoto Y, Sato M, Sasabe J, Kita Y et al. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo. J Neurosci 2005; 25: 10252–10261. · DOI
  7. Yamada M, Chiba T, Sasabe J, Terashita K, Aiso S, Matsuoka M . Nasal colivelin treatment ameliorates memory impairment related to Alzheimer's disease. Neuropsychopharmacology 2007; 33: 2020–2032. · DOI
  8. Stephanou A, Latchman DS . Opposing actions of STAT-1 and STAT-3. Growth Factors 2005; 23: 177–182. · DOI
  9. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997; 94: 3801–3804. · DOI · Paper page
  10. Gao Q, Wolfgang MJ, Neschen S, Morino K, Horvath TL, Shulman GI et al. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA 2004; 101: 4661–4666. · DOI · Paper page
  11. Kawasumi M, Chiba T, Yamada M, Miyamae-Kaneko M, Matsuoka M, Nakahara J et al. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice. Eur J Neurosci 2004; 19: 2826–2838. · DOI
  12. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996; 274: 99–102. · DOI · Paper page
  13. Yamada M, Chiba T, Sasabe J, Nawa M, Tajima T, Niikura T et al. Implanted cannula-mediated repetitive administration of Abeta25–35 into the mouse cerebral ventricle effectively impairs spatial working memory. Behav Brain Res 2005; 164: 139–146. · DOI
  14. Itoh J, Nabeshima T, Kameyama T . Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 1990; 101: 27–33. · DOI
  15. Ichihara K, Nabeshima T, Kameyama T . Differential effects of pimozide and SCH 23390 on acquisition of learning in mice. Eur J Pharmacol 1989; 164: 189–195. · DOI
  16. Mamiya T, Noda Y, Nishi M, Takeshima H, Nabeshima T . Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res 1998; 783: 236–240. · DOI
  17. Chiba T, Yamada M, Sasabe J, Terashita K, Aiso S, Matsuoka M et al. Colivelin prolongs survival of an ALS model mouse. Biochem Biophys Res Commun 2006; 343: 793–798. · DOI
  18. Berkeley JL, Levey AI . Muscarinic activation of mitogen-activated protein kinase in PC12 cells. J Neurochem 2000; 75: 487–493. · DOI
  19. Tucker BA, Rahimtula M, Mearow KM . A procedure for selecting and culturing subpopulations of neurons from rat dorsal root ganglia using magnetic beads. Brain Res Brain Res Protoc 2005; 16: 50–57. · DOI
  20. Zagrebelsky M, Holz A, Dechant G, Barde YA, Bonhoeffer T, Korte M . The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J Neurosci 2005; 25: 9989–9999. · DOI · Paper page
  21. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1–42/1–40 ratio in vitro and in vivo. Neuron 1996; 17: 1005–1013. · DOI · Paper page
  22. Gelinas DS, DaSilva K, Fenili D, St George-Hyslop P, McLaurin J . Immunotherapy for Alzheimer's disease. Proc Natl Acad Sci USA 2004; 101: 14657–14662. Review. · DOI
  23. Wilcock DM, Rojiani A, Rosenthal A, Levkowitz G, Subbarao S, Alamed J et al. Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci 2004; 24: 6144–6151. · DOI
  24. Kubo M, Hanada T, Yoshimura A . Suppressors of cytokine signaling and immunity. Nat Immunol 2003; 4: 1169–1176. Review. · DOI
  25. Ohtani T, Ishihara K, Atsumi T, Nishida K, Kaneko Y, Miyata T et al. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity 2000; 12: 95–105. · DOI
  26. Venkatasubbarao K, Choudary A, Freeman JW . Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases. Cancer Res 2005; 65: 2861–2871. · DOI
  27. Mamiya T, Ukai M . [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 2001; 134: 1597–1599. · DOI
  28. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama N, Nathanson NM et al. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 2003; 6: 51–58. · DOI
  29. Saito K, Iwashita J, Murata J, Abe T . The tyrosine kinase inhibitor AG490 inhibits growth of cancer cells and activates ERK in LS174T and HT-29 cells. Anticancer Res 2006; 26: 1085–1090.
  30. Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 2001; 108: 1781–1788. · DOI
  31. Krejcova G, Patocka J, Slaninova J . Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J Pept Sci 2004; 10: 636–639. · DOI
  32. Le Y, Gong W, Tiffany HL, Tumanov A, Nedospasov S, Shen W et al. Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J Neurosci 2001; 21: RC123. · DOI
  33. Hashimoto Y, Kaneko Y, Tsukamoto E, Frankowski H, Kouyama K, Kita Y et al. Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-beta peptides via p75NTR/PLAIDD. J Neurochem 2004; 90: 549–558. · DOI
  34. Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S et al. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 2006; 103: 7130–7135. · DOI · Paper page
  35. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007; 316: 750–754. · DOI · Paper page
  36. Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, Herman M et al. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 2007; 27: 13635–13648. · DOI
  37. Coffer PJ, van Puijenbroek A, Burgering BM, Klop-de Jonge M, Koenderman L, Bos JL et al. Insulin activates Stat3 independently of p21ras-ERK and PI-3K signal transduction. Oncogene 1997; 15: 2529–2539. · DOI
  38. Kurdi M, Booz GW . Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS. J Cell Physiol 2007; 212: 424–431. · DOI
  39. Alvarez A, Cacabelos R, Sanpedro C, Garcia-Fantini M, Aleixandre M . Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging 2007; 28: 533–536. · DOI
  40. Bartus RT, Dean III RL, Beer B, Lippa AS . The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408–417. · DOI · Paper page
  41. Berse B, Blusztajn JK . Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J Biol Chem 1995; 270: 22101–22104. · DOI
  42. Cheema SS, Arumugam D, Murray SS, Bartlett PF . Leukemia inhibitory factor maintains choline acetyltransferase expression in vivo. Neuroreport 1998; 9: 363–366. · DOI
  43. Sur C, Mallorga PJ, Wittmann M, Jacobson MA, Pascarella D, Williams JB et al. N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity. Proc Natl Acad Sci USA 2003; 100: 13674–13679. · DOI
  44. Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, Fisher A et al. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 2006; 49: 671–682. · DOI · Paper page
  45. Shmuel M, Nodel-Berner E, Hyman T, Rouvinski A, Altschuler Y . Caveolin 2 regulates endocytosis and trafficking of the M1 muscarinic receptor in MDCK epithelial cells. Mol Biol Cell 2007; 18: 1570–1585. · DOI
  46. Jasmin JF, Mercier I, Hnasko R, Cheung MW, Tanowitz HB, Dupuis J et al. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. Cardiovasc Res 2004; 63: 747–755. · DOI

Cited by

Sorted by citations

Metadata

Authors
Chiba, T., Yamada, M., Sasabe, J., Terashita, K., Shimoda, M., Matsuoka, M., & Aiso, S.
Venue
Molecular Psychiatry
Publisher
Springer Science and Business Media LLC
Published
2008-09-23
Volume
14
Issue
2
Pages
206-222
ISSN
  • 1359-4184
  • 1476-5578
DOI
10.1038/mp.2008.105
Cited by
194
References
13
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review